Original Research
Published on 20 Jul 2023
Blockage of S100A8/A9 ameliorates septic nephropathy in mice
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1172356
- 3,228 views
- 7 citations
Type at least 3 characters
563 articles
Articles
Original Research
Published on 07 Jul 2023
Rapamycin treatment induces tubular proteinuria: role of megalin-mediated protein reabsorption
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1194816
- 5,050 views
- 3 citations
Review
Published on 26 Jun 2023
Treatment of obesity-related diabetes: significance of thermogenic adipose tissue and targetable receptors
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1144918
- 3,203 views
- 2 citations
Editorial
Published on 16 Jun 2023
Editorial: Be positive about the negative in pharmacology: clinical studies in renal pharmacology 2022
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1236750
- 2,035 views
Review
Published on 15 Jun 2023
Mitochondrial homeostasis: a potential target for delaying renal aging
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1191517
- 2,853 views
- 6 citations
Original Research
Published on 13 Jun 2023
The macrocyclic lactone oxacyclododecindione reduces fibrosis progression
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1200164
- 2,156 views
- 2 citations
Correction
Published on 09 Jun 2023
Corrigendum: Phyllanthus niruri L. exerts protective effects against the calcium oxalate-induced renal injury via ellgic acid
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1207268
- 1,107 views
Original Research
Published on 08 Jun 2023
Molecular mechanism of Hedyotis Diffusae Herba in the treatment of lupus nephritis based on network pharmacology
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1118804
- 1,886 views
- 2 citations
Original Research
Published on 08 Jun 2023
The role of the SGK3/TOPK signaling pathway in the transition from acute kidney injury to chronic kidney disease
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1169054
- 4,416 views
- 3 citations
Opinion
Published on 06 Jun 2023
Dysfunction of von-Hippel Lindau factor causes reduced degradation of HIF leading to renal cancer. Hypoxia-inducible factor-prolyl hydroxylase enzyme inhibitors also lessen HIF destruction and could therefore increase renal cancer
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1170796
- 1,341 views
- 3 citations
General Commentary
Published on 30 May 2023
Commentary: Protective effect of quercetin on kidney diseases: from chemistry to herbal medicines
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1214664
- 1,956 views
Original Research
Published on 25 May 2023
APOC1 exacerbates renal fibrosis through the activation of the NF-ÎşB signaling pathway in IgAN
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1181435
- 4,522 views
- 2 citations
Systematic Review
Published on 24 May 2023
Safety of HIF prolyl hydroxylase inhibitors for anemia in dialysis patients: a systematic review and network meta-analysis
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1163908
- 6,203 views
- 8 citations
Review
Published on 23 May 2023
A comprehensive review of acute cardio-renal syndrome: need for novel biomarkers
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1152055
- 9,821 views
- 7 citations
Original Research
Published on 18 May 2023
Efficacy and safety of tacrolimus-based treatment for non-rapidly progressive IgA nephropathy
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1189608
- 1,851 views
- 2 citations
Original Research
Published on 18 May 2023
In silico evidence implicating novel mechanisms of Prunella vulgaris L. as a potential botanical drug against COVID-19-associated acute kidney injury
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1188086
- 2,615 views
- 3 citations